The cellular prion protein is preferentially expressed by CD4+ CD25+ Foxp3+ regulatory T cells
Post-translational modification of the cellular prion protein (PrPC) is intimately associated with the pathogenesis of prion disease, yet the normal function of the protein remains unclear. PrPC is expressed in lymphoid cells and is known to be a T-cell activation antigen. Further, transcription profiling studies of regulatory T cells have shown preferential overexpression of PrPC, suggesting a possible role in regulatory function. We report that both the expression of PrP message and cell surface PrPC levels are increased in murine CD4+ CD25+ regulatory T cells compared with CD4+ CD25− cells. However, PrP0/0 mice do not show altered regulatory T-cell numbers or forkhead box P3 (Foxp3) expression levels, or impaired regulatory T-cell function in vitro. Nevertheless, the preferential expression of surface PrPC by regulatory T cells raises the possibility that therapeutic ligation of PrPC might alter immune regulation.
Document Type: Research Article
Affiliations: 1: MRC Prion Unit, Department of Neurodegenerative Disease, Institute of Neurology, University College London, London, UK 2: Human Disease Immunogenetics Group, Department of Infectious Diseases and Immunity, Imperial College, Hammersmith Hospital, London, UK
Publication date: November 1, 2008